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rable to that obtained using the microneurographic tech-
nique.4,6,9 Being less affected by the conduction time of
the afferent somatosensory fiber and by central process-
ing, SuCV may be a useful parameter with which to evalu-
ate efferent sudomotor function. Denisˇlicˇ et al., however,
noted that it is not based on the activity of the same un-
myelinated axons and sweat glands.1 Elie et al., who tried
to determine SuCV in the lower extremities of normal
subjects, failed to obtain SSRs at the proximal site (inner
side of the thigh) in 13 of 30 subjects.4 Further study is
needed to determine the meaning of the decrease in
SuCV.
The SSR amplitude varies greatly even in normal sub-
jects; therefore, some authors have suggested that ampli-
tude is an unreliable parameter for SSR,3,9 but others have
reported the SSR amplitude is important clinically.8,10 We
agree with the opinion expressed by Denisˇlicˇ et al. that the
presence or absence of SSR is only one aspect of the over-
all considerations. The problem of variability may be coun-
tered, to some extent, by using an amplitude parameter
with reproducibility. Although all SSR amplitude param-
eters in our study showed considerable inter- and intrasub-
ject variability, the maximum amplitude gave the best re-
sults in terms of reproducibility (Fig. 1). High intersubject
variability, shown as a large standard deviation (SD) value
or coefficient of variation across subjects (CVAS), makes it
difficult to set a normative range of SSR amplitudes. For
example, we found that the mean maximum amplitude (n
= 35) minus 2 SD gives a value below 0 mV. We think a
definition of normative range based on percentile would
be practical. The log transformation also is used to achieve
normality.5
Latency showed less variation than the SSR amplitude.
In our study the mean value (n = 35) of the mean laten-
cies of 20 SSRs in each subject was 7.1% of the CVAS,
which corresponds to the value for minimum F latency
(6.1%, median nerve and 7.0%, tibial nerve)7 obtained
for 45 normal subjects. In terms of the other reported
SSR latency CVAS (4.7% to 12.9%),4,6,8,9 our 7.1% is
an intermediate value. If the normative range is defined
as the mean ± 2.5 SD (range 1.16–1.66 s), only one
measurement in the 82 total test sessions, including the
follow-up examination (n = 35), would be beyond this
range.
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VARIATION IN THE TREATMENT OF
CARPAL TUNNEL SYNDROME
Carpal tunnel syndrome (CTS) is a common disorder, es-
pecially among female adults.1 No consensus exists with
respect to the treatment of choice of CTS. Some physicians
prefer early surgery in electrophysiologically confirmed
CTS cases without an underlying reversible disorder,4 but
others refer to the potential complications of surgery and
support conservative therapy as the first treatment option
of CTS.2
In order to assess the current practice of neurologists
in The Netherlands regarding the treatment of CTS, a
questionnaire was sent to each of 134 Dutch neurological
practices. The questionnaire included queries regarding
the preferred initial treatment, the annual frequency of
the responders’ application of various treatment modali-
ties (never versus ever), and the responders’ opinion of
the acceptability of early surgery as the first treatment op-
tion of CTS.
The questionnaire was returned by 92 (69%) represen-
tatives of the 134 neurological practices. Early surgery was
indicated as the preferred initial treatment of a CTS pa-
tient by 36 neurologists (39%), whereas 37 neurologists
(40%) preferred conservative treatment. The remaining
19 responders (21%) reported either surgery or conserva-
tive therapy as the preferred initial treatment (Table 1).
Regarding the annual frequency of the responders’ appli-
cation of various treatment modalities (data not shown),
wrist splinting (76%) and referral for surgery (88%) were
the most frequently mentioned CTS treatments. Local cor-
ticosteroid injections, systemic corticosteroid therapy, an-
algesics, physiotherapy, and pyridoxine were mentioned
by 20 (22%), 2 (2%), 21 (23%), 6 (7%), and 1 (1%)
responders, respectively. For only 4 neurologists (4%),
early surgery was not acceptable.
We conclude that both in the medical literature2,4 and
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in a relatively small country like The Netherlands there is
no consensus regarding the optimal treatment of CTS.
This might be due to the lack of scientific evidence of the
efficacy of the various treatment modalities for CTS.3 To
date, the medical literature does not support the selection
of either early surgery or conservative management as the
treatment of choice for CTS. Conservative management
seems to be attractive because it is easily applicable and not
very demanding. However, recovery might occur more
quickly after early surgery, resulting in a shorter duration
of the disease.
Therefore, properly designed randomized clinical tri-
als comparing the efficacy of early surgery with conserva-
tive management (e.g., immobilization of the wrist by
splinting) with a sufficient number of patients and relevant
outcome measures are urgently needed to enable the se-
lection of the best treatment option for patients with car-
pal tunnel syndrome.
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SELECTIVE BILATERAL AMYOTROPHY
OF THE ANTERIOR TIBIAL MUSCLE: A
CASE REPORT
Numerous instances of unilateral muscular atrophy involv-
ing only a single muscle in either the upper or lower limb
have been reported in Japan,6–9 and less frequently in the
western countries.1,2,4,5 Most of these conditions involve
muscle wasting of neurogenic origin. Here we describe a
male patient, aged 22, with a selective amyotrophy affect-
ing only the anterior tibial muscle in both legs.
The patient was in good health until age 19, when he
started experiencing difficulties in flexing his feet. The
patient was brought to our attention at age 21. Examina-
tion showed marked bilateral wasting of the tibialis ante-
rior muscle. Dorsiflexion of the feet was not possible.
Muscle strength was normal in all other muscles exam-
ined. Electromyogram (EMG) of the anterior tibial muscle
showed bilateral changes with positive potentials and fi-
brillations. During maximal voluntary effort, only a single
motor unit discharge per insertion could be recorded. F-
wave latency recorded from extensor digitorum brevis by
stimulating the deep peroneal nerve was normal. All other
muscles were normal by EMG. A muscle computed tomog-
raphy (CT) scan showed hypodensity of the anterior tibial
muscles (Fig. 1B). By magnetic resonance imaging (MRI),
the spinal cord was shown to be of normal diameter
throughout. The muscle CT scan was normal for both par-
ents. A skeletal muscle biopsy was obtained from the right
tibialis anterior muscle. Light microscopy showed a mark-
edly increased variation in fiber size. Interstitial connective
tissue was increased (Fig. 1A). Some atrophic muscle fibers
showed clusters of nuclei. Adenosine triphosphatase reac-
tion was uniform under all conditions. We believe that this
case can be classified with previously reported instances of
selective muscle amyotrophy. To date no isolated cases in
which only the anterior tibial muscle was affected in both
limbs have been described. Similar cases previously de-
scribed all significantly differ from the present case. Most
of the similar cases reported in the literature are con-
cerned with monomelic amyotrophy.1,2,4–9 Some authors
have described segmental atrophy of the spinal cord using
myelography and postmyelographic CT.10 We performed
an MRI of the spinal cord in our patient, but could not
demonstrate a segmental spinal cord atrophy. A clinical
case similar to our patient’s, but involving the bilateral
quadriceps femoris, was reported in 2 patients by Fu-
rukawa et al.3 and Serratrice et al.12 A familial form of
symmetrical anterior tibial muscular dystrophy has been
described in Finland by Udd et al.13 The lack of dystrophic
change and the normal muscle CT scan in the parents of
Table 1. Preferred initial treatment of patients with carpal
tunnel syndrome according to 92 representatives of Dutch
neurologic practices.
Treatment
modality
No. of
responders
(%)
Surgery 36 (39.1%)
Conservative management 37 (40.2%)
Wrist splinting 24 (26.1%)
Corticosteroid injection into
the carpal canal 4 (4.3%)
Splinting and/or
corticosteroid injection 3 (3.3%)
Splinting and/or analgesics 3 (3.3%)
Splinting and/or systemic
corticosteroids 1 (1.1%)
Systemic corticosteroids 1 (1.1%)
Pyridoxine (vitamin B6) 1 (1.1%)
Either surgery or conservative management 19 (20.7%)
Surgery or wrist splinting 13 (14.1%)
Surgery or another conservative
treatment 6 (6.5%)
Percentage of total between brackets.
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